DE2934069A1 - Mittel gegen theileriosen und seine verwendung. - Google Patents
Mittel gegen theileriosen und seine verwendung.Info
- Publication number
- DE2934069A1 DE2934069A1 DE19792934069 DE2934069A DE2934069A1 DE 2934069 A1 DE2934069 A1 DE 2934069A1 DE 19792934069 DE19792934069 DE 19792934069 DE 2934069 A DE2934069 A DE 2934069A DE 2934069 A1 DE2934069 A1 DE 2934069A1
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- agent against
- theileriosis
- carbon atoms
- theilerios
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000001117 Theileriasis Diseases 0.000 title claims description 9
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical compound C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 125000003544 oxime group Chemical group 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 241000238876 Acari Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000223777 Theileria Species 0.000 description 2
- 241000223778 Theileria annulata Species 0.000 description 2
- 241000223779 Theileria parva Species 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 208000003495 Coccidiosis Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- 241000594011 Leuciscus leuciscus Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000009182 Parasitemia Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 241001299692 Theileria lestoquardi Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792934069 DE2934069A1 (de) | 1979-08-23 | 1979-08-23 | Mittel gegen theileriosen und seine verwendung. |
| EG80504A EG14600A (en) | 1979-08-23 | 1980-07-19 | Preparing for combating theileriosis and their use |
| IL60890A IL60890A (en) | 1979-08-23 | 1980-08-21 | Preparation for the treatment of theileriosis containing piperidylacetonylquinazolinone derivatives and some new such compounds |
| ZM67/80A ZM6780A1 (en) | 1979-08-23 | 1980-08-21 | Preparations for the treatment of theileriosis and their use |
| US06/180,016 US4340596A (en) | 1979-08-23 | 1980-08-21 | Preparations for the treatment of theileriosis and their use |
| CH6325/80A CH649545A5 (de) | 1979-08-23 | 1980-08-21 | Arzneimittel gegen theileriosen. |
| MW30/80A MW3080A1 (en) | 1979-08-23 | 1980-08-21 | Preparations for the treatment of theileriosis and their use |
| ZW196/80A ZW19680A1 (en) | 1979-08-23 | 1980-08-21 | Preparations for the treatment of theileriosis and their use |
| FR8018351A FR2468368A1 (fr) | 1979-08-23 | 1980-08-22 | Agent pour le traitement de theilerioses a base de quinazolinone |
| GB8027354A GB2057439B (en) | 1979-08-23 | 1980-08-22 | Quinazolinones |
| OA57198A OA06599A (fr) | 1979-08-23 | 1980-08-22 | Procédé de préparation d'un agent pour le traitement de théilérioses. |
| MA19140A MA18939A1 (fr) | 1979-08-23 | 1980-08-22 | Procede de preparation d'un agent pour le traitement de theilerioses |
| BE0/201860A BE884917A (fr) | 1979-08-23 | 1980-08-25 | Agent pour le traitement de theilerioses et son application |
| DE19803035567 DE3035567A1 (de) | 1979-08-23 | 1980-09-20 | Mittel gegen theileriosen, neue chinazolinonsalze und ihre verwendung |
| FR8026199A FR2468602A1 (fr) | 1979-08-23 | 1980-12-10 | Nouveaux derives de quinazolinone |
| KE3382A KE3382A (en) | 1979-08-23 | 1984-03-01 | Compounds and preparations for the treatment of theileriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792934069 DE2934069A1 (de) | 1979-08-23 | 1979-08-23 | Mittel gegen theileriosen und seine verwendung. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2934069A1 true DE2934069A1 (de) | 1981-03-12 |
| DE2934069C2 DE2934069C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-02-15 |
Family
ID=6079087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19792934069 Granted DE2934069A1 (de) | 1979-08-23 | 1979-08-23 | Mittel gegen theileriosen und seine verwendung. |
Country Status (14)
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1155358B (it) * | 1982-07-06 | 1987-01-28 | Vetem Spa | Derivati chinazolinonici attivi contro la coccidiosi |
| US4906635A (en) * | 1983-11-25 | 1990-03-06 | Schering Corporation | Carboxyalkyl dipeptides as antiglaucoma agents |
| US5017567A (en) * | 1983-11-25 | 1991-05-21 | Schering Corporation | Carboxyalkyl dipeptides as antiglaucoma agents |
| US4778795A (en) * | 1983-11-25 | 1988-10-18 | Schering Corporation | Carboxyalkyl dipeptides as antiglaucoma agents |
| US4762838A (en) * | 1985-08-30 | 1988-08-09 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
| US4797486A (en) * | 1986-09-08 | 1989-01-10 | Pfizer Inc. | Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents |
| DE3638445A1 (de) * | 1986-11-11 | 1988-05-26 | Hoechst Ag | Coccidiozide mittel |
| US4849518A (en) * | 1987-06-22 | 1989-07-18 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
| US4920224A (en) * | 1988-03-24 | 1990-04-24 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
| AU3467493A (en) * | 1992-01-27 | 1993-09-01 | Board Of Trustees Of The Leland Stanford Junior University | Histamine derivatives and methods for their use |
| IL110831A (en) * | 1994-08-31 | 1998-12-27 | Hadasit Med Res Service | Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis |
| IL112125A (en) * | 1994-12-22 | 1998-02-08 | Hadasit Med Res Service | Quinazolinone-containing pharmaceutical compositions |
| US5998422A (en) * | 1994-12-12 | 1999-12-07 | Agricultural Research Organization, Ministry Of Agriculture | Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
| US6090814A (en) * | 1995-08-15 | 2000-07-18 | Agricultural Research Organization Ministry Of Agriculture | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization |
| IL114951A (en) * | 1995-08-15 | 1999-08-17 | Hadasit Med Res Service | Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization |
| WO1998023244A2 (en) * | 1996-08-30 | 1998-06-04 | Davidson, Clifford, M. | Intracoronary stents containing quinazolinone derivatives |
| US6028075A (en) * | 1997-02-11 | 2000-02-22 | Pines; Mark | Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| US6159488A (en) * | 1997-08-14 | 2000-12-12 | Agricultural Research Org. Ministry Of Agriculture (Gov.) | Intracoronary stents containing quinazolinone derivatives |
| AU756437B2 (en) * | 1998-08-13 | 2003-01-16 | Agricultural Research Organization, Ministry Of Agricultural, State Of Israel | Inhibition of pathogenic processes related to tissue trauma |
| IL148292A (en) * | 2002-02-21 | 2008-08-07 | Shai Yarkoni | Stable preparations of lupoginone and other quinazolinone derivatives |
| WO2006090376A2 (en) * | 2005-02-23 | 2006-08-31 | Collgard Biopharmaceuticals Ltd. | Pharmaceutical compositions of the isolated d- enantiomer of the quinazolinone derivative halofuginone |
| EP2010136B1 (en) * | 2006-04-10 | 2012-09-12 | The President and Fellows of Harvard College | Methods for modulating formation and progression of cellulite |
| US20110212100A1 (en) * | 2007-08-15 | 2011-09-01 | Tracy Keller | Methods for modulating development and expansion of il-17 expressing cells |
| AU2009282480B2 (en) * | 2008-08-11 | 2015-05-07 | Children's Medical Center Corporation | Halofuginone analogs for inhibition of tRNA synthetases and uses thereof |
| US10155742B2 (en) | 2012-01-13 | 2018-12-18 | President And Fellows Of Harvard College | Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions |
| EP2845588A1 (en) * | 2013-09-09 | 2015-03-11 | Centre National de la Recherche Scientifique (C.N.R.S.) | PIN1 inhibitors for use in the prevention and/or treatment of theileriosis, and related applications |
| US11708353B2 (en) | 2018-06-08 | 2023-07-25 | The General Hospital Corporation | Inhibitors of prolyl-tRNA-synthetase |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2694711A (en) * | 1952-12-02 | 1954-11-16 | American Cyanamid Co | Quinazolone antimalarial compounds |
| US3320124A (en) * | 1964-07-20 | 1967-05-16 | American Cyanamid Co | Method for treating coccidiosis with quinazolinones |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE505711A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1950-09-09 |
-
1979
- 1979-08-23 DE DE19792934069 patent/DE2934069A1/de active Granted
-
1980
- 1980-07-19 EG EG80504A patent/EG14600A/xx active
- 1980-08-21 IL IL60890A patent/IL60890A/xx unknown
- 1980-08-21 ZM ZM67/80A patent/ZM6780A1/xx unknown
- 1980-08-21 CH CH6325/80A patent/CH649545A5/de not_active IP Right Cessation
- 1980-08-21 MW MW30/80A patent/MW3080A1/xx unknown
- 1980-08-21 US US06/180,016 patent/US4340596A/en not_active Expired - Lifetime
- 1980-08-21 ZW ZW196/80A patent/ZW19680A1/xx unknown
- 1980-08-22 OA OA57198A patent/OA06599A/xx unknown
- 1980-08-22 MA MA19140A patent/MA18939A1/fr unknown
- 1980-08-22 FR FR8018351A patent/FR2468368A1/fr active Granted
- 1980-08-22 GB GB8027354A patent/GB2057439B/en not_active Expired
- 1980-08-25 BE BE0/201860A patent/BE884917A/fr not_active IP Right Cessation
- 1980-12-10 FR FR8026199A patent/FR2468602A1/fr active Granted
-
1984
- 1984-03-01 KE KE3382A patent/KE3382A/xx unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2694711A (en) * | 1952-12-02 | 1954-11-16 | American Cyanamid Co | Quinazolone antimalarial compounds |
| US3320124A (en) * | 1964-07-20 | 1967-05-16 | American Cyanamid Co | Method for treating coccidiosis with quinazolinones |
Non-Patent Citations (1)
| Title |
|---|
| PSCHYREMBEL, W.: Klinisches Wörterbuch, 253. Aufl., 1977, S. 987 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ZW19680A1 (en) | 1981-03-11 |
| CH649545A5 (de) | 1985-05-31 |
| OA06599A (fr) | 1981-08-31 |
| ZM6780A1 (en) | 1981-10-21 |
| IL60890A (en) | 1983-09-30 |
| IL60890A0 (en) | 1980-10-26 |
| MA18939A1 (fr) | 1981-04-01 |
| MW3080A1 (en) | 1981-08-12 |
| DE2934069C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-02-15 |
| EG14600A (en) | 1985-03-31 |
| FR2468368B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1983-07-08 |
| KE3382A (en) | 1984-03-23 |
| BE884917A (fr) | 1981-02-25 |
| FR2468368A1 (fr) | 1981-05-08 |
| FR2468602A1 (fr) | 1981-05-08 |
| FR2468602B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1983-07-22 |
| GB2057439B (en) | 1983-06-22 |
| GB2057439A (en) | 1981-04-01 |
| US4340596A (en) | 1982-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2934069A1 (de) | Mittel gegen theileriosen und seine verwendung. | |
| EP0240829B1 (de) | Cancerostatisches Mittel | |
| DE3689220T2 (de) | Hemmung der In-vitro-Infektivität und des zytopathischen Effektes von HTLV-III/LAV durch 2'3'-Dideoxyinosin, 2'3'-Dideoxyguanosin oder 2'3'-Dideoxyadenosin. | |
| CH662945A5 (de) | Ophthalmische loesung. | |
| DE4117371A1 (de) | Antimykotische mittel, die phenylessigsaeurederivate enthalten | |
| DE3942638C2 (de) | Anti-Aidsviralagenzien | |
| Brunsdon | Seasonal changes in the level and composition of nematode worm burdens in young sheep | |
| DE60038106T3 (de) | Anthelmintische zusammensetzungen | |
| DE60023720T2 (de) | Zusammensetzung für inhalierung enthaltend delta-9-tetrahydrocannabinol in einem semi-wässrigen lösungsmittel | |
| EP0152836A2 (de) | Mittel zur oralen Hygiene | |
| EP0185210A2 (de) | Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Behandlung von an amyotropher Lateralsklerose Erkrankten | |
| DE3119746C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE4017964C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE69213757T2 (de) | Verwendung von kreatinphosphat oder phosphoenolbrenztraubensäure zur behandlung von tumoren | |
| DE2655690A1 (de) | Arzneimittelzubereitungen | |
| DE2225548C3 (de) | Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis | |
| EP0967980B1 (de) | Verwendung von aminothiazolen zur wund- und hautbehandlung | |
| EP0293714A1 (de) | Neue Kombinationspräparate mit antidepressiver Wirkung | |
| DE60115237T2 (de) | Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien | |
| DE2314387C3 (de) | Arzneimittel zur Behandlung bösartiger Neubildungen | |
| DE60012183T2 (de) | Verwendung einer makrolid-verbindung zur herstellung eines medikaments zur behandlung von gehirnschäden aufgrund von ischämie oder blutungen | |
| Gibson et al. | An evaluation of the anthelmintic pyrantel tartrate using the improved controlled test | |
| DE3780702T2 (de) | Verwendung von etodolac zur senkung des blutgehalts an harnsaeure. | |
| DE2110537C3 (de) | N-Pyridyl-brenzschleimsäureamide, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE3637649A1 (de) | Verwendung von 4-chinolon-derivaten zur bekaempfung von protozoen und helminthen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AG | Has addition no. |
Ref country code: DE Ref document number: 3035567 Format of ref document f/p: P |
|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| AG | Has addition no. |
Ref country code: DE Ref document number: 3035567 Format of ref document f/p: P |
|
| 8339 | Ceased/non-payment of the annual fee |